Abstract Purpose Sexual and gender minority people (SGM) experience multiple cancer-related disparities, including higher rates of cancer risk factors, lower rates of cancer screening, higher lifetime risk of cancer, and unmet needs throughout cancer survivorship. Although many national organizations, including the National Cancer Institute (NCI) and the American Cancer Society (ACS), have emphasized the need for more cancer research among SGM communities, currently no consensus exists about the highest research priorities, promising research models, or mechanisms to support collaboration between geographically dispersed scientific teams. Methods To address this gap, we convened a three-day conference to focus on the “Science of Cancer Health Equity for SGM Communities.” Held at the New York University (NYU) Langone Medical Center Campus in New York City from October 5–7, 2023, this conference brought together researchers, trainees, early-stage investigators, and community members. The conference aimed to: 1) examine the current span of evidence-based research on SGM cancer across the cancer control continuum; 2) establish SGM cancer research priorities; 3) promote the careers and research of trainees and early stage investigators, especially those from minoritized backgrounds; 4) develop a transdisciplinary network of professionals with a focus on mentorship and shared research methods; and 5) disseminate findings from this conference, including priorities for SGM cancer health equity research. Results Response to the conference was overwhelmingly positive. Conclusion The success of this inaugural conference indicated the need for additional efforts to advance SGM cancer research and expand on scientific priorities.
Kamen et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: